Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

MARK4 Antibody

Product Specifications

Product Name Alternative

MARK4; KIAA1860; MARKL1; MAP/microtubule affinity-regulating kinase 4; MAP/microtubule affinity-regulating kinase-like 1

Swiss Prot

Q96L34

Host

Rabbit

Reactivity

Human, Mouse

Immunogen

The antiserum was produced against synthesized peptide derived from human MARK4. AA range:461-510

Target

MARK4

Partner Proteins

MAP/microtubule affinity-regulating kinase 4

Clonality

Polyclonal

Source

Polyclonal, Rabbit,IgG

Applications

IF, ELISA

Purification

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Dilution

IF 1:200 - 1:1000. ELISA: 1:40000. Not yet tested in other applications.

Modification

Unmodified/Total

Storage Conditions

Store at -20°C/1 year

Product Datasheet

https://www.assaybiotechnology.com/image/catalog/abtdatasheets/C11511.pdf

Product MSDS

https://www.assaybiotechnology.com/image/Antibody_SDS.pdf

Specificity

MARK4 Polyclonal Antibody detects endogenous levels of MARK4 protein.

Formulation

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

CAS Number

9007-83-4

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NTF4 AAV Vector (Rat) (CMV)
32236106 1 μg

NTF4 AAV Vector (Rat) (CMV)

Ask
View Details
STK17B (Serine/threonine-protein Kinase 17B, DAP Kinase-related Apoptosis-inducing Protein Kinase 2, DRAK2) APC
MBS6139333-01 0.1 mL

STK17B (Serine/threonine-protein Kinase 17B, DAP Kinase-related Apoptosis-inducing Protein Kinase 2, DRAK2) APC

Ask
View Details
STK17B (Serine/threonine-protein Kinase 17B, DAP Kinase-related Apoptosis-inducing Protein Kinase 2, DRAK2) APC
MBS6139333-02 5x 0.1 mL

STK17B (Serine/threonine-protein Kinase 17B, DAP Kinase-related Apoptosis-inducing Protein Kinase 2, DRAK2) APC

Ask
View Details
(1R,2R) -N1, N1-Bis (2- (di-p-Tolylphosphino) Benzyl) Cyclohexane-1,2-Diamine
OR1026200-01 100 mg

(1R,2R) -N1, N1-Bis (2- (di-p-Tolylphosphino) Benzyl) Cyclohexane-1,2-Diamine

Ask
View Details
(1R,2R) -N1, N1-Bis (2- (di-p-Tolylphosphino) Benzyl) Cyclohexane-1,2-Diamine
OR1026200-02 250 mg

(1R,2R) -N1, N1-Bis (2- (di-p-Tolylphosphino) Benzyl) Cyclohexane-1,2-Diamine

Ask
View Details
(1R,2R) -N1, N1-Bis (2- (di-p-Tolylphosphino) Benzyl) Cyclohexane-1,2-Diamine
OR1026200-03 1 g

(1R,2R) -N1, N1-Bis (2- (di-p-Tolylphosphino) Benzyl) Cyclohexane-1,2-Diamine

Ask
View Details